NEW YORK (GenomeWeb News) – Global Genomics Group and Caprion Proteomics said today that they have entered into a collaboration to investigate potential biomarkers and pharmaceutical targets for cardiovascular disease.

Under the agreement, Caprion will identify blood-based protein markers for the ongoing GLOBAL (Genetic Loci and Burden of Atherosclerotic Lesions) study, a multi-center pan-omic study that aims to recruit up to 10,000 patients to characterize disease pathways and biomarkers linked to coronary artery disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.